The life and death of breast cancer cells: proposing a role for the effects of oestrogen and phytoestrogens on potassium channels
| dc.contributor.author | Wallace, J. | |
| dc.contributor.author | Gow, Iain F. | |
| dc.contributor.author | Warnock, Mary | |
| dc.contributor.sponsor | QMU Bursary | |
| dc.date.accessioned | 2018-06-29T21:33:05Z | |
| dc.date.available | 2018-06-29T21:33:05Z | |
| dc.date.issued | 2011-07-15 | |
| dc.description.abstract | Changes in the regulation of potassium channels are increasingly implicated in the altered activity of breast cancer cells. Increased or reduced expression of a number of K+ channels have been identified in numerous breast cancer cell lines and cancerous tissue biopsy samples, compared to normal tissue, and are associated with tumor formation and spread, enhanced levels of proliferation, and resistance to apoptotic stimuli. Through knockout or silencing of K+ channel genes, and use of specific or more broad pharmacologic K+ channel blockers, the growth of numerous cell lines, including breast cancer cells, has been modified. In this manner it has been proposed that in MCF7 breast cancer cells proliferation appears to be regulated by the activity of a number of K+ channels, including the Ca2+ activated K+ channels, and the voltage-gated K+ channels hEAG and Kv1.1. The effect of phytoestrogens on K+ channels has not been extensively studied but yields some interesting results. In a number of cell lines the phytoestrogen genistein inhibits K+ current through several channels including Kv1.3 and hERG. Where it has been used, structurally similar daidzein has little or no effect on K+ channel activity. Since many K+ channels have roles in proliferation and apoptosis in breast cancer cells, the impact of K+ channel regulation by phytoestrogens is of potentially great relevance. | |
| dc.description.eprintid | 2423 | |
| dc.description.faculty | sch_die | |
| dc.description.ispublished | pub | |
| dc.description.number | 2 | |
| dc.description.referencetext | Abdul M, Santo A, Hoosein N (2003) Activity of potassium channelblockers in breast cancer. Anticancer Res 23:3347-3351 Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S (2000) Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10:127-135 Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P, MacEwan DJ (1999) Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 274:9539-9547 Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P, Crociani O, Rosati B, Faravelli L, Olivotto M, Wanke E (1998) herg encodes a K? current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 58:815-822 Birch PJ, Dekker LV, James IF, Southan A, Cronk D (2004) Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain. Drug Discov Today 9: 410-418 Borowiec AS, Hague F, Harir N, Guenin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K, Ouadid-Ahidouch H (2007) IGF-1 activates hEAG K(?) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol 212:690-701 Bortner CD, Cidlowski JA (1999) Caspase independent/dependent regulation of K(?), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J Biol Chem 274: 21953-21962 Brevet M, Ahidouch A, Sevestre H, Merviel P, El Hiani Y, Robbe M, Ouadid-Ahidouch H (2008) Expression of K? channels in normal and cancerous human breast. Histol Histopathol 23: 965-972 Cahalan MD, Wulff H, Chandy KG (2001) Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol 21:235-252 Cayabyab FS, Schlichter LC (2002) Regulation of an ERG K? current by Src tyrosine kinase. J Biol Chem 277:13673-13681 Chen MX, Gorman SA, Benson B, Singh K, Hieble JP, Michel MC, Tate SN, Trezise DJ (2004) Small and intermediate conductance Ca(2?)-activated K? channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn Schmiedebergs Arch Pharmacol 369:602-615 Chen SZ, Jiang M, Zhen YS (2005) HERG K? channel expressionrelated chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother Pharmacol 56:212-220 Cherubini A, Taddei GL, Crociani O, Paglierani M, Buccoliero AM, Fontana L, Noci I, Borri P, Borrani E, Giachi M, Becchetti A, Rosati B, Wanke E, Olivotto M, Arcangeli A (2000) HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br J Cancer 83:1722-1729 Chiang CE, Luk HN, Chen LL, Wang TM, Ding PYA (2002) Genistein inhibits the inward rectifying potassium current in guinea pig ventricular myocytes. J Biomed Sci 9:321-326 Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H (2005) 17-Betaestradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. FEBS Lett 579: 2995-3000 Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, Matifat F (2007) The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol 71:843-851 Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Gui P, Hill MA, Wilson E (2001) Regulation of ion channels by protein tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 281:H1835- H1862 Dhar MS, Plummer HK III (2006) Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells. BMC Physiol 6:8 Dixon RA (2004) Phytoestrogens. Annu Rev Plant Biol 55:225-261 Dong MQ, Sun HY, Tang Q, Tse HF, Lau CP, Li GR (2010) Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase. Biochim Biophys Acta 1798:995-1001 Enyedi P, Czirjak G (2010) Molecular background of leak K? currents: two-pore domain potassium channels. Physiol Rev 90:559-605 Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, Aiyar J (1999) Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 274: 5746-5754 Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez- Marmol R, Sole L, Ferreres JC, Condom E (2006) Potassium channels: new targets in cancer therapy. Cancer Detect Prev 30:375-385 Gao Z, Lau CP, Wong TM, Li GR (2004) Protein tyrosine kinasedependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell Signal 16:333-341 Garcia-Ferreiro RE, Kerschensteiner D, Major F, Monje F, Stuhmer W, Pardo LA (2004) Mechanism of block of hEag1 K? channels by imipramine and astemizole. J Gen Physiol 124:301-317 Gierten J, Ficker E, Bloehs R, Schlomer K, Kathofer S, Scholz E, Zitron E, Kiesecker C, Bauer A, Becker R, Katus HA, Karle CA, Thomas D (2008) Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein. Br J Pharmacol 154:1680-1690 Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S (2005) International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 57:527-540 Gow IF, Thomson J, Davidson J, Shennan DB (2005) The effect of a hyposmotic shock and purinergic agonists on K?(Rb?) efflux from cultured human breast cancer cells. Biochim Biophys Acta 1712:52-61 Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13:698-708 Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG (1994) Pharmacological characterization of five cloned voltage-gated K? channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227-1234 Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X (2005) International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 57:473-508 Hadsell DL (2003) The insulin-like growth factor system in normal mammary gland function. Breast Dis 17:3-14 Haider S, Knofler M (2009) Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 30:111-123 Haren N, Khorsi H, Faouzi M, Ahidouch A, Sevestre H, Ouadid- Ahidouch H (2010) Intermediate conductance Ca2? activated K? channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. Histol Histopathol 25:1247-1255 Harvey AL, Robertson B (2004) Dendrotoxins: structure-activity relationships and effects on potassium ion channels. Curr Med Chem 11:3065-3072 Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knotgen H, Sanchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz JR, Stuhmer W, Pardo LA (2006) Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5:41 Hille B (2001) Ion channels of excitable membranes, 3rd edn. Sinauer Associates, Sunderland, MA Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA (1997) Intracellular K? suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272:30567-30576 HUGO Gene Nomenclature Committee (2011) HUGO Gene Nomenclature Committee Database. http://www.genenames.org Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO (2006) Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101:246-253 International Union of Pharmacology (2011) IUPHAR Committee on Receptor Nomenclature and Drug Classification Database. http://www.iuphar-db.org Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S (2008) Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Centerbased prospective study group. J Clin Oncol 26:1677-1683 Jang SH, Kang KS, Ryu PD, Lee SY (2009) Kv1.3 voltage-gated K(?) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep 42:535-539 Jin Q, Esteva FJ (2008) Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia 13:485-498 Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA, Couraud PO, Ningaraj NS (2009) Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer 9:258 Koeberle PD, Wang Y, Schlichter LC (2010) Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 17: 134-144 Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA (2005) International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 57:509-526 Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-4263 Lastraioli E, Guasti L, Crociani O, Polvani S, Hofmann G, Witchel H, Bencini L, Calistri M, Messerini L, Scatizzi M, Moretti R, Wanke E, Olivotto M, Mugnai G, Arcangeli A (2004) herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 64:606-611 Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, Ji BT, Gao J, Gao YT, Zheng W (2009) Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Womens Health Study. Am J Clin Nutr 89:1920-1926 Li HF, Chen SA, Wu SN (2000) Evidence for the stimulatory effect of resveratrol on Ca(2?)-activated K? current in vascular endothelial cells. Cardiovasc Res 45:1035-1045 Li Z, Joyal JL, Sacks DB (2001) Calmodulin enhances the stability of the estrogen receptor. J Biol Chem 276:17354-17360 Li X, Zhang S, Safe S (2006) Activation of kinase pathways in MCF- 7 cells by 17beta-estradiol and structurally diverse estrogenic compounds. J Steroid Biochem Mol Biol 98:122-132 Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J (2008) Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro 22:1749-1753 Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando S (2001) Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 60:595-602 Matsumura A,Ghosh A, Pope GS, Darbre PD(2005) Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94:431-443 Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804 Missan S, Linsdell P, McDonald TF (2006) Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K? current in guinea-pig ventricular myocytes. J Physiol 573(pt 2):469-482 Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KCQ, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie WR, Wigler MH, Powers S (2003) Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3:297-302 Ouadid-Ahidouch H, Ahidouch A (2008) K? channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol 221:1-6 Ouadid-Ahidouch H, Chaussade F, Roudbaraki M, Slomianny C, Dewailly E, Delcourt P, Prevarskaya N (2000) KV1.1 K(?) channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem Biophys Res Commun 278:272-277 Ouadid-Ahidouch H, Roudbaraki M, Ahidouch A, Delcourt P, Prevarskaya N (2004a) Cell-cycle-dependent expression of the large Ca2?-activated K? channels in breast cancer cells. Biochem Biophys Res Commun 316:244-251 Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, Ahidouch A, Joury N, Prevarskaya N (2004b) Functional and molecular identification of intermediate-conductance Ca(2?)-activated K(?) channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 287:C125-C134 Pardo LA (2004) Voltage-gated potassium channels in cell proliferation. Physiology 19:285-292 Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stuhmer W (2005) Role of voltage-gated potassium channels in cancer. J Membr Biol 205:115-124 Park WS, Firth AL, Han J, Ko EA (2010) Patho-, physiological roles of voltage-dependent K? channels in pulmonary arterial smooth muscle cells. J Smooth Muscle Res 46:89-105 Peterson G, Barnes S (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 7:1345-1351 Pillozzi S, Brizzi MF, Balzi M, Crociani O, Cherubini A, Guasti L, Bartolozzi B, Becchetti A, Wanke E, Bernabei PA, Olivotto M, Pegoraro L, Arcangeli A (2002) HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 16:1791-1798 Rodriguez-Mora OG, LaHair MM, McCubrey JA, Franklin RA (2005) Calcium/calmodulin-dependent kinase I and calcium/ calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 65:5408-5416 Roger S, Potier M, Vandier C, Le Guennec JY, Besson P (2004) Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells. Biochim Biophys Acta 1667:190-199 Roy J, Vantol B, Cowley EA, Blay J, Linsdell P (2008) Pharmacological separation of hEAG and hERG K? channel function in the human mammary carcinoma cell line MCF-7. Oncol Rep 19:1511-1516 Sakamoto T, Horiguchi H, Oguma E, Kayama F (2010) Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem 21:856-864 Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF III, Guinosso PJ Jr, Lynch JJ Jr (1995) Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76:110-119 Shi X, Cheng Y, Zou L, Xiong D, Zhou Y, Yang M, Fan D, Dai X, Yang C, Zhu H (2011) Influence of the calmodulin antagonist EBB on cyclin B1 and cdc2-p34 in human drug-resistant breast cancer MCF-7/ADR cells. Chin J Clin Oncol 5:108-112 Shim HY, Park JH, Paik HD, Nah SY, Kim DSHL, Han YS (2007) Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anticancer Drugs 18:649-657 So FV, Guthrie N, Chambers AF, Carroll KK (1997) Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 112:127-133 Stephan D, Winkler M, Kuhner P, Russ U, Quast U (2006) Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels. Diabetologia 49:2039-2048 Stringer BK, Cooper AG, Shepard SB (2001) Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. Cancer Res 61:582-588 Strobl JS, Wonderlin WF, Flynn DC (1995) Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 26: 1643-1649 Sun XH, Ding JP, Li H, Pan N, Gan L, Yang XL, Xu HB (2007) Activation of large-conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarinmediated vasodilation. J Pharmacol Exp Ther 323:391-397 Suzuki T, Matsuo K, Tsunoda N, Hirose K, Hiraki A, Kawase T, Yamashita T, Iwata H, Tanaka H, Tajima K (2008) Effect of soybean on breast cancer according to receptor status: a casecontrol study in Japan. Int J Cancer 123:1674-1680 Szabo I, Bock J, Grassme H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E (2008) Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci USA 105:14861-14866 Teisseyre A, Michalak K (2005) Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes. J Membr Biol 205:71-79 Teisseyre A, Michalak K (2006) Inhibition of the activity of human lymphocyte Kv1.3 potassium channels by resveratrol. J Membr Biol 214:123-129 Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459-471 Vaidyanathan R, Taffet SM, Vikstrom KL, Anumonwo JMB (2010) Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97. J Biol Chem 285:28000-28009 Verkasalo PK, Appleby PN, Allen NE, Davey G, Adlercreutz H, Key TJ (2001) Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br J Nutr 86:415-421 Vu CC, Bortner CD, Cidlowski JA (2001) Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death. J Biol Chem 276:37602-37611 Wang Z (2004) Roles of K? channels in regulating tumour cell proliferation and apoptosis. Eur J Physiol 448:274-286 Wang H, Zhang Y, Cao L, Han H, Wang J, Yang B, Nattel S, Wang Z (2002) HERG K? channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62:4843-4848 Weber C, Mello de Queiroz F, Downie BR, Suckow A, Stuhmer W, Pardo LA (2006) Silencing the activity and proliferative properties of the human EagI potassium channel by RNA interference. J Biol Chem 281:13030-13037 Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H (2005) International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 57:463-472 Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H (2009) Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabetes Metab Res Rev 25:41-49 Wonderlin WF, Strobl JS (1996) Potassium channels, proliferation and G1 progression. J Membr Biol 154:91-107 Wu WKK, Li GR, Wong HPS, Hui MKC, Tai EKK, Lam EKY, Shin VY, Ye YN, Li P, Yang YH, Luo JC, Cho CH (2006) Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells. J Cell Physiol 207:437-444 Yao X, Kwan HY (1999) Activity of voltage-gated K? channels is associated with cell proliferation and Ca2? influx in carcinoma cells of colon cancer. Life Sci 65:55-62 Zava DT, Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27:31-40 Zhang ZH, Wang Q (2000) Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein. Pflugers Arch 440:784-792 Zhang DY, Wang Y, Lau CP, Tse HF, Li GR (2008) Both EGFR kinase and Src-related tyrosine kinases regulate human ether-a-go-gorelated gene potassium channels. Cell Signal 20:1815-1821 Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT (1998) Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74:230-241 Ziechner U, Schonherr R, Born AK, Gavrilova-Ruch O, Glaser RW, Malesevic M, Kullertz G, Heinemann SH (2006) Inhibition of human ether a go-go potassium channels by Ca2?/calmodulin binding to the cytosolic N- and C-termini. FEBS J 273:1074-1086 | |
| dc.description.status | pub | |
| dc.description.volume | 242 | |
| dc.format.extent | 53-67 | |
| dc.identifier | ER2423 | |
| dc.identifier.citation | Wallace, J.L., Gow, I.F. and Warnock, M. (2011) ‘The life and death of breast cancer cells: proposing a role for the effects of phytoestrogens on potassium channels’, The Journal of Membrane Biology, 242(2), pp. 53–67. Available at: https://doi.org/10.1007/s00232-011-9376-4. | |
| dc.identifier.doi | http://10.1007/s00232-011-9376-4 | |
| dc.identifier.issn | 0022-2631 | |
| dc.identifier.uri | http://dx.doi.org/10.1007/s00232-011-9376-4 | |
| dc.identifier.uri | https://eresearch.qmu.ac.uk/handle/20.500.12289/2423 | |
| dc.publisher | Springer | |
| dc.relation.ispartof | Journal of Membrane Biology | |
| dc.subject | Breast cancer | |
| dc.subject | Daidzein | |
| dc.subject | Genistein | |
| dc.subject | hEAG | |
| dc.subject | hERG | |
| dc.subject | Isoflavone | |
| dc.subject | Kv1.1 | |
| dc.subject | Kv1.3 | |
| dc.subject | MCF7 | |
| dc.subject | Potassium channel | |
| dc.title | The life and death of breast cancer cells: proposing a role for the effects of oestrogen and phytoestrogens on potassium channels | |
| dc.type | article | |
| dcterms.accessRights | restricted | |
| qmu.author | Warnock, Mary | |
| qmu.author | Wallace, J. | |
| qmu.author | Gow, Iain F. | |
| rioxxterms.type | article |
Files
Original bundle
1 - 1 of 1